Loading...
Abuse Liability, Anti-Nociceptive, and Discriminative Stimulus Properties of IBNtxA
[Image: see text] IBNtxA (3-iodobenzoyl naltrexamine) is a novel μ-opioid receptor (MOR) agonist which is structurally related to the MOR antagonist naltrexone. Recent studies suggest IBNtxA preferentially signals through truncated MOR splice variants, resulting in anti-nociception with reduced side...
Na minha lista:
| Udgivet i: | ACS Pharmacol Transl Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American
Chemical Society
2020
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7551712/ https://ncbi.nlm.nih.gov/pubmed/33073190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00066 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|